Article

Remdesivir Treatment alters Circulating MicroRNA Profile in Coronavirus Disease 2019 (COVID-19) Patients

2023-03-20

Abstract excerpt

<title>Abstract</title> <p>Coronavirus disease 2019 (COVID-19), a serious infectious disease caused by the newly discovered Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents a significant global health crisis nowadays. Although no specific antiviral drug has been proven to be fully effective against COVID-19, Remdesivir (GS-5734), a nucleoside analogue prodrug, showed beneficial effects upo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f7c3d19-1b39-5cd0-8555-df700bc49d22
DOI: 10.21203/rs.3.rs-1372258/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Remdesivir Treatment alters Circulating MicroRNA Profile in Coronavirus Disease 2019 (COVID-19) PatientsDOI 10.21203/rs.3.rs-1372258/v1Read

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary resultsSemantic proximity Read

Evaluation of altered miRNA expression pattern to predict COVID-19 severity.Semantic proximity Read

MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?Semantic proximity Read

COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/ProfileSemantic proximity Read

Altered microRNA expression in severe COVID‐19: Potential prognostic and pathophysiological roleSemantic proximity Read

Integration of the circulating miRNome and clinical information to predict 90-day mortality in elderly COVID-19 subphenotypesSemantic proximity Read

Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.Semantic proximity Read

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemicSemantic proximity Read

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron waveSemantic proximity Read

Differential microRNA expression in the peripheral blood from human patients with COVID‐19Semantic proximity Read

Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)Semantic proximity Read

miRNAs; a novel strategy for the treatment of COVID‐19Semantic proximity Read